SEC Form 4 · accession 0001179110-18-006569
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President & CEO · Director
Period of report
May 8, 2018
Accepted (ET)
May 10, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2018 | M | 5,781 | $0.00 | A | 203,360 | D | |
| Common StockF3 | May 8, 2018 | S | 2,601 | $20.21 | D | 200,759 | D | |
| Common Stock | holding | — | — | — | 339,645 | I | Craig Wheeler Revocable Trust | |
| Common Stock | holding | — | — | — | 45,980 | I | Craig A Wheeler 2016 Annuity Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | — | May 8, 2018 | M | 5,781 | D | — | — | Common Stock | 5,781 | 63,594 | D |
Explanation of responses
- F1Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person August 7, 2017.
- F3This transaction was executed in multiple trades at prices ranging from $17.05 to $21.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4Restricted Stock Units convert into common stock on a one-for-one basis.
- F5Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.